Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib

Systemic mastocytosis, in the context of a deleterious germline SDHC variant, treated with ripretinib

Bibliographic Details
Main Authors:	Sara Saheb Kashaf, MPhil, Lucy A. Godley, MD, PhD, Angad Chadha, MD, Jason B. Waldinger, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Series:	JAAD Case Reports
Subjects:	alopecia chronic myeloproliferative neoplasm germline SDHC mutation ripretinib systemic mastocytosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512623001200

Similar Items

Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial
by: Patrick Schöffski, et al.
Published: (2022-12-01)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
by: Wang H, et al.
Published: (2023-11-01)

Mastocytosis in the Skin: Disease Heterogeneity among Children and Adults
by: Christos Fokoloros, et al.
Published: (2023-01-01)

Systemic Lymphadenopathic Mastocytosis with Eosinophilia
by: Soyoung Im, et al.
Published: (2022-12-01)

Cutaneous Mastocytosis in Childhood—Update from the Literature
by: Florica Sandru, et al.
Published: (2021-04-01)

Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study
by: Su Yin Lim, et al.
Published: (2024-02-01)

Urticaria pigmentosa and systemic mastocytosis
by: Jonathan Keow, et al.
Published: (2023-12-01)

Germline <i>ERBB2</i>/<i>HER2</i> Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms
by: Evan M. Braunstein, et al.
Published: (2021-06-01)

Efficacy and safety of ripretinib in Chinese patients with advanced gastrointestinal stromal tumors: a real-world, multicenter, observational study
by: Weili Yang, et al.
Published: (2023-05-01)

Occurrence of Unexpected Adverse Reactions to Vaccines in Children with Mastocytosis
by: Hanna Abuhay, et al.
Published: (2020-03-01)

Mastocytosis—A Review of Disease Spectrum with Imaging Correlation
by: Ahmed Elsaiey, et al.
Published: (2021-10-01)

Systemic mastocytosis in Croatia
by: Ivan Krečak, et al.
Published: (2022-10-01)

Primary cutaneous lymphoma in a patient with mastocytosis: Is there an association?
by: Colin M. Kincaid, BS, et al.
Published: (2023-06-01)

Diffuse Cutaneous Mastocytosis: A Current Understanding of a Rare Disease
by: Agnieszka Rydz, et al.
Published: (2024-01-01)

Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
by: Magda Zanelli, et al.
Published: (2021-01-01)

Pseudoxanthomatous diffuse cutaneous mastocytosis in a child
by: Ritu Gujarati Vishwanath, et al.
Published: (2023-07-01)

Retrospective Evaluation of Childhood Cutaneous Mastocytosis Cases
by: Burcu Akıncı, et al.
Published: (2020-03-01)

Childhood cutaneous mastocytosis: Revisited
by: Bhavya Swarnkar, et al.
Published: (2023-01-01)

The diagnostic workup for systemic mastocytosis differs from consensus recommendations: Results of a worldwide survey
by: Polina Pyatilova, MD, et al.
Published: (2023-11-01)

Unusual presentation of maculopapular cutaneous mastocytosis in an infant with skin of color
by: Christopher Markeson, BS, et al.
Published: (2023-08-01)

Management of Cutaneous Mastocytosis during Childhood: Update from the Literature
by: Öner Özdemir
Published: (2024-02-01)

Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review
by: Yefan Zhang, et al.
Published: (2023-05-01)

The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome
by: Elena Masselli, et al.
Published: (2021-09-01)

Simultaneous diagnosis of papillary thyroid cancer and systemic mastocytosis
by: Kevin F. Brown, et al.
Published: (2023-07-01)

Metformin: A potential adjunct for treatment of systemic mastocytosis
by: Joseph H. Butterfield, MD, et al.
Published: (2024-02-01)

Bullous Mastocytosis Mimicking Congenital Epidermolysis Bullosa
by: Julio Cesar Salas-Alanis, et al.
Published: (2014-05-01)

Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
by: Prapassorn Thirasastr, et al.
Published: (2024-02-01)

Dermoscopic Features of Different Forms of Cutaneous Mastocytosis: A Systematic Review
by: Martyna Sławińska, et al.
Published: (2022-08-01)

Target Therapies for Systemic Mastocytosis: An Update
by: Mariarita Sciumè, et al.
Published: (2022-06-01)

Current Challenges in the Diagnosis of Pediatric Cutaneous Mastocytosis
by: Hanna Ługowska-Umer, et al.
Published: (2023-12-01)

A case of indolent systemic mastocytosis responding to treatment with Avapritinib
by: Terrence Sun, et al.
Published: (2024-02-01)

Cognitive, neuropsychiatric and neurological alterations in mastocytosis: A systematic review
by: Elena Sagües‐Sesé, et al.
Published: (2023-12-01)

Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview
by: Mauro Cancian, et al.
Published: (2019-08-01)

Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond
by: Bettina Sprinzl, et al.
Published: (2021-02-01)

Osteoporosis and Osteopathy Markers in Patients with Mastocytosis
by: Nilüfer Alpay Kanıtez, et al.
Published: (2015-02-01)

Challenges in the Diagnosis of Cutaneous Mastocytosis
by: Knut Brockow, et al.
Published: (2024-01-01)

Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?
by: Antonella Zagaria, et al.
Published: (2017-08-01)

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
by: Knut Brockow, et al.
Published: (2021-03-01)

Bone Marrow Mastocytosis: A Diagnostic Challenge
by: Roberta Zanotti, et al.
Published: (2021-04-01)

A Comprehensive Review of Mastocytosis From Pathophysiology to Management Strategies
by: Magdalena Marchaj, et al.
Published: (2024-04-01)